Holen Sie sich die Stockscreener-App
22.19
3.79%
0.81
Handel nachbörslich:
22.19
Schlusskurs vom Vortag:
$21.38
Offen:
$21.37
24-Stunden-Volumen:
1.40M
Relative Volume:
2.17
Marktkapitalisierung:
$997.06M
Einnahmen:
$681.75M
Nettoeinkommen (Verlust:
$70.47M
KGV:
15.30
EPS:
1.45
Netto-Cashflow:
$173.19M
1W Leistung:
+4.03%
1M Leistung:
-10.67%
6M Leistung:
-16.11%
1J Leistung:
+33.92%
1-Tages-Spanne:
$21.37
$22.74
1-Wochen-Bereich:
$20.70
$22.74
52-Wochen-Spanne:
$16.00
$27.98
Pacira Biosciences Inc Stock (PCRX) Company Profile
Firmenname
Pacira Biosciences Inc
Sektor
Telefon
650-242-8052
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Vergleichen Sie PCRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCRX
Pacira Biosciences Inc
|
22.19 | 960.66M | 681.75M | 70.47M | 173.19M | 1.45 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Hochstufung | Truist | Hold → Buy |
| 2025-01-30 | Hochstufung | Truist | Sell → Hold |
| 2024-08-13 | Herabstufung | Truist | Buy → Sell |
| 2024-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2024-08-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-08-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-08-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-07-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-03-07 | Fortgesetzt | JP Morgan | Overweight |
| 2023-12-20 | Eingeleitet | Raymond James | Outperform |
| 2023-08-03 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-01-31 | Fortgesetzt | Wedbush | Outperform |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-01-03 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-26 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-21 | Fortgesetzt | JP Morgan | Neutral |
| 2021-04-09 | Eingeleitet | Berenberg | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-11 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2021-01-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-09-21 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-06 | Bestätigt | Needham | Buy |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-04-07 | Eingeleitet | Northland Capital | Outperform |
| 2020-03-20 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-02-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2019-11-06 | Eingeleitet | BTIG Research | Buy |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-06 | Hochstufung | Mizuho | Underperform → Neutral |
| 2019-05-02 | Hochstufung | Stifel | Sell → Hold |
| 2019-02-01 | Herabstufung | Mizuho | Neutral → Underperform |
| 2018-08-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-21 | Bestätigt | Mizuho | Neutral |
| 2018-02-16 | Herabstufung | Needham | Buy → Hold |
| 2018-01-19 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-01-04 | Bestätigt | Canaccord Genuity | Buy |
| 2018-01-03 | Eingeleitet | Leerink Partners | Mkt Perform |
Alle ansehen
Pacira Biosciences Inc Aktie (PCRX) Neueste Nachrichten
Is Pacira BioSciences Inc. stock supported by strong fundamentalsMarket Trend Report & Growth Focused Entry Reports - newser.com
Will Pacira BioSciences Inc. (82P) stock rise with strong economy2025 Retail Activity & Long-Term Safe Investment Plans - newser.com
Why Pacira BioSciences Inc. (82P) stock could outperform next yearJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Is Pacira BioSciences Inc. stock poised for growthJuly 2025 Big Picture & Accurate Intraday Trading Signals - newser.com
Should I hold or sell Pacira BioSciences Inc. stock in 2025Gap Down & Weekly Market Pulse Alerts - newser.com
Using data tools to time your Pacira BioSciences Inc. exitMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
How Pacira BioSciences Inc. stock valuations compare to rivals2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com
Real time social sentiment graph for Pacira BioSciences Inc.Price Action & Reliable Entry Point Trade Alerts - newser.com
Pacira BioSciences Inc. recovery potential after sell off2025 Growth vs Value & Scalable Portfolio Growth Methods - newser.com
How to integrate Pacira BioSciences Inc. into portfolio analysis toolsTrade Entry Report & Free Verified High Yield Trade Plans - newser.com
What is the fair value estimate for Pacira BioSciences Inc. (82P) stock in 2025Risk Management & Daily Profit Focused Screening - newser.com
Pacira BioSciences Inc. stock retracement – recovery analysisInflation Watch & Real-Time Buy Signal Alerts - newser.com
Can a trend reversal in Pacira BioSciences Inc. lead to recoveryTrade Volume Summary & Weekly Top Gainers Alerts - newser.com
Will Pacira BioSciences Inc. stock keep outperforming rivalsGlobal Markets & High Return Stock Watch Alerts - newser.com
Building trade automation scripts for Pacira BioSciences Inc.Quarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
How Pacira BioSciences Inc. stock trades before earningsMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Connect - ACCESS Newswire
2025-11-02 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Connect | NDAQ:PCRX | Press Release - Stockhouse
Pacira BioSciences, Inc. (PCRX) Stock Forecasts - Yahoo Finance
Pacira BioSciences, Inc. (PCRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Chart based analysis of Pacira BioSciences Inc. trendsTrade Volume Summary & Growth Focused Stock Reports - newser.com
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025 - markets.businessinsider.com
Pacira Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Trends - Markets Mojo
Pacira BioSciences (PCRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Pacira BioSciences, Inc. (PCRX) Stock forecasts - Yahoo! Finance UK
Finanzdaten der Pacira Biosciences Inc-Aktie (PCRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):